M

Melior Discovery

31 employees

Melior Discovery offers a pharmacology platform to identify novel indications for pre-clinical development stage drug candidates.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
phenotypic screening
theraTRACE
rodent models of disease
Biopharma
diabetes
Parkinson's Disease
multiplexing
behavioral assays
drug repurposing
In vivo pharmacology
drug repositioning
drug reprofiling
in vivo models of efficacy

Date founded

2005

Funding rounds raised

Total raised

$2.5M

from 6 investors over 6 rounds

M

Melior Discovery raised undisclosed on June 20, 2012

Investors: BioAdvance

M

Melior Discovery raised undisclosed on December 14, 2011

Investors: BioAdvance

M

Melior Discovery raised undisclosed on April 21, 2010

Investors: BioAdvance

M

Melior Discovery raised undisclosed on June 11, 2007

Investors: BioAdvance

M

Melior Discovery raised $2.5M on April 5, 2006

Investors: Osage Partners

M

Melior Discovery raised $500K on January 25, 2005

Investors: BioAdvance

FAQ